Common Variants Affecting Susceptibility to Develop Multiple Basal Cell Carcinomas

Journal of Investigative Dermatology

Volumn 135, Issue 8, 2015, Pages 2135-2138

  Verkouteren, Joris A C ^a   Pardo, Luba M ^a   Uitterlinden, André G ^a   Hofman, Albert ^a   Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; FHIT GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ADULT; AGED; COMPARATIVE STUDY; CONGENITAL TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; SKIN TUMOR; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS;

EID: 84937636954     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.113     Document Type: Letter

References (15)

1. Barnes LD, Garrison PN, Siprashvili Z et al. (1996) Fhit, a putative tumor suppressor in humans, is a dinucleoside 5', 5"'-P1, P3-triphosphate hydrolase. Biochemistry 35:11529-35
2. Casparie M, Tiebosch AT, Burger G et al. (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29: 19-24
3. Cerimele D, Contu L, Carcassi C et al. (1988) HLA and multiple skin carcinomas. Dermatologica 176:176-81
4. Ding Y, Larson G, Rivas G et al. (2008) Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS One 3:e3533
5. Flohil SC, van der Leest RJ, Arends LR et al. (2013) Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 49:2365-75
6. Goldberg M, Rummelt C, Laerm A et al. (2006) Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas. Br J Dermatol 155:1154-8
7. Hofman A, Darwish Murad S, van Duijn CM et al. (2013) The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28: 889-926
8. Hollestein LM, de Vries E, Aarts MJ et al. (2014) Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989. J Am Acad Dermatol 71: 896-903
9. Housman TS, Feldman SR, Williford PM et al. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48:425-9
10. Howie B, Fuchsberger C, Stephens M et al. (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955-9
11. Lear JT, Heagerty AH, Smith A et al. (1996) Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cyto-chrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis 17:1891-6
12. Ohta M, Inoue H, Cotticelli MG et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-97
13. Purcell S, Neale B, Todd-Brown K et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-75
14. Ramachandran S, Hoban PR, Ichii-Jones F et al. (2000) Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours. Pharmacogenetics 10: 545-56
15. Rompel R, Petres J, Kaupert K et al. (1995) Human leukocyte antigens and multiple basal cell carcinomas. Recent Results Cancer Res 139: 297-302